The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
- 1 April 2002
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 16 (4) , 486-507
- https://doi.org/10.1038/sj.leu.2402460
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 323 references indexed in Scilit:
- Structure−Activity Relationships for 5-Substituted 1-Phenylbenzimidazoles as Selective Inhibitors of the Platelet-Derived Growth Factor ReceptorJournal of Medicinal Chemistry, 1999
- Induction of NF-κB by the Akt/PKB kinaseCurrent Biology, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- In VitroInhibition of Ras–Raf Association by Short PeptidesBiochemical and Biophysical Research Communications, 1998
- Activation Mechanism of the MAP Kinase ERK2 by Dual PhosphorylationCell, 1997
- Role of Protein Phosphatase 2A in the Regulation of Mitogen-Activated Protein Kinase Activity in Ventricular CardiomyocytesBiochemical and Biophysical Research Communications, 1996
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumorsToxicology Letters, 1993
- Transformation suppressor activity of a Jun transcription factor lacking its activation domainNature, 1991
- ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGFCell, 1991